Yuo
Akira Yuo, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20110151554 | METHOD FOR CULTURING AND SUBCULTURING PRIMATE EMBRYONIC STEM CELL, AS WELL AS METHOD FOR INDUCING DIFFERENTIATION THEREOF - The present invention provides a method for subculturing primate embryonic stem cells, and a method for inducing differentiation of the same cell into a vascular endothelial cell and a blood cell. The present invention provides a method comprising culturing primate embryonic stem cells in a medium containing a protein component without using feeder cells and cytokines in a container coated with an extracellular matrix, detaching colonies of the resulting embryonic stem cells in the presence of a cytodetachment agent, and plating the colonies in the similar medium, and a method comprising culturing primate embryonic stem cells in a serum-containing or not containing medium in the presence of cytokine, adhesion-culturing the resulting embryoid body or embroyid body-analogous cellular aggregate in the presence of a cytokine to obtain specific precursor cells, and separating non-adherent cells and adherent cells from the specific precursor cells to obtain blood cells and vascular endothelial precursor cells. | 06-23-2011 |
20140140967 | PLURIPOTENT STEM CELL-DERIVED BROWN ADIPOCYTES, PLURIPOTENT STEM CELL-DERIVED CELL AGGREGATE, METHOD FOR PRODUCING SAME, AND CELL THERAPY AND MEDICAL THERAPY THEREFOR - Provided are a method of producing brown adipocytes from pluripotent stem cells, a method of producing cell aggregates as an intermediate product thereof, pluripotent stem cell-derived cell aggregates and pluripotent stem cell-derived brown adipocytes produced by these methods, and cell therapy using the pluripotent stem cell-derived brown adipocytes. In the method of producing brown adipocytes from pluripotent stem cells, cell aggregates are produced from pluripotent stem cells by a method including the step (A), and brown adipocytes are prepared from the cell aggregates by a method including the step (B). The step (A) is a step of producing cell aggregates by non-adhesive culture of pluripotent stem cells in serum-free environment in the presence of a hematopoietic cytokine, and the step (B) is a step of producing brown adipocytes by adhesion culture of the cell aggregates in the presence of a hematopoietic cytokine. | 05-22-2014 |
Chung-Yee Yuo, Kaohsiung City TW
Patent application number | Description | Published |
---|---|---|
20100152204 | TREATMENT FOR SPINAL MUSCULAR ATROPHY - A method of treating spinal muscular atrophy. The method includes administering an effective amount of composition including a sodium-proton exchanger inhibitor and a pharmaceutically acceptable carrier or salt, to a subject with spinal muscular atrophy to ameliorate a symptom of spinal muscular atrophy. | 06-17-2010 |
20110319353 | TREATMENT FOR SPINAL MUSCULAR ATROPHY - A method of treating spinal muscular atrophy. The method includes administering an effective amount of composition including a sodium-proton exchanger inhibitor and a pharmaceutically acceptable carrier or salt, to a subject with spinal muscular atrophy to ameliorate a symptom of spinal muscular atrophy. | 12-29-2011 |
Sungho Yuo, Namdong-Gu KR
Patent application number | Description | Published |
---|---|---|
20130135362 | DATA DRIVER DRIVING METHOD FOR REDUCING GAMMA SETTLING TIME AND DISPLAY DRIVE DEVICE - A data driver driving method includes separately generating gamma voltages through respective separate gamma voltage generators according to colors, applying the separate gamma voltages to their corresponding drive circuits in a data driver through separate channels to obtain first, second, and third color converting outputs, and alternately and sequentially applying the first, second, and third color converting outputs to common pixel nodes of a panel. | 05-30-2013 |
Wen-Ping Yuo, Kaohsiung City TW
Patent application number | Description | Published |
---|---|---|
20120202164 | Orthodontic Maxillary Micro Implant - An orthodontic maxillary micro implant includes a plate and a corrective accessory. The plate is implanted into the keratinized epidermal tissue in the maxilla of the orthodontic patient's oral cavity. First and second locking elements are passed through first and second locking holes situated at both ends of the plate respectively to secure the plate to the maxilla, and finally a third locking element is affixed through a fourth locking hole situated on the corrective accessory and a third locking hole situated on the plate to secure the corrective accessory to the maxilla. The orthodontic maxillary micro implant overcomes the difficulty of tongue operation and reduced oral hygiene maintenance caused by the large surface area that a conventional maxillary device occupies. With the use of orthodontic wires, the orthodontic maxillary micro implant becomes an orthodontic accessory allowing the patient's teeth to be moved backward, pulled forward, pushed sideways or retracted. | 08-09-2012 |